Over the past fifteen years, we have seen a concerning rise in “nuclear verdicts,” or jury awards of $10 million or more. While this development undoubtedly benefits contingency fee plaintiffs’ lawyers, it presents significant potential adverse consequences to corporate defendants and the people they employ. This article explores the data concerning the rise in nuclear verdicts and introduces the Dentons US Trial Strategy Series.
Dentons – Insights – Read More
